YD Bio Limited Ordinary Shares
YDES | NASDAQ
$2.86
+$0.23 (+8.75%)
Sep 22, 2026, 2:11 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -97.86 | -35.36 | 62.24K | 29.54 | 20.24 | -69.39 |
PEG Ratio | 1.25 | 0 | -622.68 | -0.97 | -0.05 | n/a |
PS Ratio | 1.36K | 97.81 | 2.41K | n/a | n/a | n/a |
PB Ratio | -284.80 | 7.57 | 36.7K | 9.99 | 1.62 | 1.76 |
P/FCF Ratio | -101.20 | -10.51 | -15.08K | -37.02 | -255.89 | -694.29 |
P/OCF Ratio | -123.29 | -27.18 | -15.16K | -37.02 | -255.89 | -694.27 |
OCF/S Ratio | -1.11K | -359.91 | -15.90 | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 2.07 | n/a | n/a | n/a |
Quick Ratio | 4.74 | 13.04 | 0.68 | 0.04 | 0.06 | 2.75 |
Current Ratio | 5.88 | 13.18 | 0.91 | 0.04 | 0.06 | 2.75 |
Asset Turnover | 0.04 | 0.07 | 1.09 | n/a | n/a | n/a |
Interest Coverage | n/a | -1.89K | -4.59 | n/a | n/a | n/a |
Return on Equity | 291.05% | -21.42% | 58.97% | 33.83% | 7.99% | -2.54% |
Return on Assets | -60.32% | -20.56% | 4.22% | 21.12% | 7.37% | -2.16% |
Return on Invested Capital | -43.41% | -22.09% | -10.72% | -18.75% | -1.48% | -0.29% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -7.06% | 30.44% | 43.83% | n/a | n/a | n/a |
Net Profit Margin | -1.39K% | -276.58% | 3.87% | n/a | n/a | n/a |
Pretax Profit Margin | -1.39K% | -271.67% | 5.04% | n/a | n/a | n/a |
Operating Profit Margin | -883.31% | -286.45% | -2.81% | n/a | n/a | n/a |
FCF Margin | -1.35K% | -930.29% | -15.98% | n/a | n/a | n/a |
EBITDA Margin | -848.19% | -250.99% | 6.35% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove YDES